Janus Henderson Group PLC boosted its position in shares of Aetna Inc. (NYSE:AET) by 9,446.2% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,328,900 shares of the company’s stock after acquiring an additional 4,283,553 shares during the quarter. Janus Henderson Group PLC owned 1.30% of Aetna worth $657,255,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in AET. State of Tennessee Treasury Department increased its position in shares of Aetna by 26.3% during the second quarter. State of Tennessee Treasury Department now owns 557,814 shares of the company’s stock worth $84,692,000 after acquiring an additional 116,280 shares during the period. Pictet & Cie Europe SA acquired a new stake in shares of Aetna in the second quarter valued at $2,269,000. Banque Pictet & Cie SA purchased a new position in Aetna in the second quarter valued at $10,567,000. NBT Bank N A NY purchased a new position in Aetna in the second quarter valued at $215,000. Finally, Swiss National Bank boosted its holdings in Aetna by 0.8% in the second quarter. Swiss National Bank now owns 1,483,438 shares of the company’s stock valued at $225,230,000 after purchasing an additional 11,100 shares during the period. Institutional investors own 89.52% of the company’s stock.

In other news, President Karen S. Lynch sold 15,271 shares of Aetna stock in a transaction dated Monday, September 18th. The shares were sold at an average price of $161.91, for a total value of $2,472,527.61. Following the completion of the transaction, the president now directly owns 64,261 shares of the company’s stock, valued at approximately $10,404,498.51. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Margaret M. Mccarthy sold 10,288 shares of the business’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the sale, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at approximately $5,465,734.55. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by corporate insiders.

Aetna Inc. (AET) traded up 0.25% during midday trading on Wednesday, hitting $163.41. The stock had a trading volume of 578,729 shares. Aetna Inc. has a 12-month low of $104.59 and a 12-month high of $164.52. The company has a market cap of $54.27 billion, a price-to-earnings ratio of 36.27 and a beta of 0.53. The company has a 50-day moving average price of $157.72 and a 200-day moving average price of $147.43.

Aetna (NYSE:AET) last released its quarterly earnings data on Thursday, August 3rd. The company reported $3.42 EPS for the quarter, topping analysts’ consensus estimates of $2.34 by $1.08. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The firm had revenue of $15.52 billion during the quarter, compared to the consensus estimate of $15.34 billion. During the same quarter in the previous year, the company posted $2.21 earnings per share. The firm’s revenue was down 2.7% on a year-over-year basis. Equities analysts anticipate that Aetna Inc. will post $9.55 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Thursday, October 12th will be issued a dividend of $0.50 per share. The ex-dividend date is Wednesday, October 11th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.23%. Aetna’s dividend payout ratio (DPR) is 43.67%.

Several equities research analysts have weighed in on the company. Deutsche Bank AG upped their price target on Aetna from $144.00 to $157.00 and gave the stock a “hold” rating in a report on Thursday, July 13th. Credit Suisse Group reiterated an “outperform” rating and issued a $165.00 price objective (up previously from $160.00) on shares of Aetna in a research note on Thursday, July 13th. Jefferies Group LLC reissued a “hold” rating and set a $163.00 price objective (up from $157.00) on shares of Aetna in a research report on Friday, August 4th. Cantor Fitzgerald reissued an “overweight” rating and set a $175.00 price objective (up from $150.00) on shares of Aetna in a research report on Wednesday, August 9th. Finally, Zacks Investment Research upgraded shares of Aetna from a “hold” rating to a “buy” rating and set a $170.00 target price on the stock in a research note on Tuesday, July 4th. Eight investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $160.77.

ILLEGAL ACTIVITY WARNING: This news story was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright law. The legal version of this news story can be read at https://www.thecerbatgem.com/2017/10/04/janus-henderson-group-plc-boosts-position-in-aetna-inc-aet.html.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Stock Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related stocks with our FREE daily email newsletter.